The diagnostics technology developer has raised another $290m from existing investor Roche, which will support it as it looks to expand its products to additional cancers.

Synthetic DNA producer DNA Script and personalised health plan provider Transcarent each closed $200m corporate-backed series C rounds.

The footfall analytics software developer scored a $1bn valuation through a series C round featuring Majestic Realty, the latest real estate operator to invest in the property data sector.

The digital education services provider was valued at $3.4bn in a Prosus-led round which included fellow corporates Tencent, Deutsche Telekom and SoftBank.

SoftBank's Latin America Fund took part in the construction materials marketplace’s latest round at a reported valuation of $800m.

Business-focused neobank Qonto raised $552m from investors including Tencent at a $552m valuation while SK provided $350m for Center for CDMO Breakthrough Medicines.

Country Garden Venture Capital returned to reinvest in Bluepha having led the the bioplastics developer’s series B2 round five months ago.

SoftBank is hopping on the meal-kit bandwagon having acquired a stake in Gousto at a valuation of $1.75bn.

Raw materials provider Vital Thin Film secured $188m in a round co-led by BYD while drug developers CinCor and Vigil raised a total of $292m in their initial public offerings.